Pfizer Inc. (PFE) and BioNTech SE (BNTX) said over the weekend that the change they made to their COVID-19 vaccine that targets the omicron variant is both safe and effective. The announcement comes as the U.S. Food and Drug Administration considers this week if it should order a formula change for vaccines in hopes that the modified vaccines could protect against another COVID-19 surge that is expected in the fall and the winter. The seven-day average of new daily COVID-19 cases was 102,818 on Sunday, the third-straight day above the 100,000 mark, and up 14% from two weeks ago, according to a New York Times Tracker. The daily average of hospitalizations rose to 31,591, up 6% form two weeks ago and the most since March 9, while daily deaths increased 5% from two weeks ago to 348.
Any recommendation, opinion or advice regarding securities or markets contained in such material does not reflect the views of TD Ameritrade, and TD Ameritrade does not verify any information included in such material.